Wertpapiere

Name Mnemo Börse Durchschn. Volumen Kurs Typ
ELISA OYJ 615402

Nasdaq Helsinki +6 Andere

294 658 42,7 EUR Aktie Elisa Oyj Aktie
ELISA OYJ 615402

Deutsche Boerse AG

24 42 EUR Aktie Elisa Oyj
ELISA OYJ 615402

London S.E.

- 42,65 EUR Aktie Elisa Oyj
ELISA OYJ 615402

Börse Stuttgart

- 42,24 EUR Aktie Elisa Oyj
ELISA OYJ 615402

BOERSE MUENCHEN

- 42,8 EUR Aktie Elisa Oyj
ELISA OYJ 615402

OTC Markets

629 45,16 USD Aktie Elisa Oyj
ELISA OYJ 615402

Berne S.E.

- - CHF Aktie Elisa Oyj
ELISA OYJ A14W0T

OTC Markets

27 24 USD Aktie Elisa Oyj Aktie
ELISA OYJ (EI6) - ELA/C5

Euronext Amsterdam

- 42,18 EUR Future ELISA OYJ (EI6) - ELA/C5 Future
ELISA OYJ (EI6) - ELA/C6

Euronext Amsterdam

- 42,53 EUR Future ELISA OYJ (EI6) - ELA/C6 Future
ELISA OYJ (EI6) - ELA/C2

Euronext Amsterdam

- 42,56 EUR Future ELISA OYJ (EI6) - ELA/C2 Future
ELISA OYJ (EI6) - ELA/20241220

Euronext Amsterdam

- 42,47 EUR Future ELISA OYJ (EI6) - ELA/20241220 Future
ELISA OYJ (EI6) - ELA/C1

Euronext Amsterdam

- 42,4 EUR Future ELISA OYJ (EI6) - ELA/C1 Future
ELISA OYJ (EI6) - ELA/C3

Euronext Amsterdam

- 42,64 EUR Future ELISA OYJ (EI6) - ELA/C3 Future
ELISA OYJ (EI6) - ELA/C4

Euronext Amsterdam

- 42,92 EUR Future ELISA OYJ (EI6) - ELA/C4 Future
ELISA OYJ (EI6) - ELA/20240620

Euronext Amsterdam

- 42,8 EUR Future ELISA OYJ (EI6) - ELA/20240620 Future

Unternehmen (17)

BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. 11 929 Mio $
Logo Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

Beijing Wantai Biopharmaceutical Co., Ltd. ist ein Unternehmen, das sich hauptsächlich mit der Forschung und Entwicklung, der Produktion und dem Vertrieb von In-vitro-Diagnostika beschäftigt. Das Unternehmen produziert und vertreibt In-vitro-Diagnostika, ...

ELISA OYJ 7 433 Mio $
Logo Elisa Oyj

Elisa Oyj ist die Nr. 1 der privaten Telekommunikationsunternehmen in Finnland. Der Nettoumsatz verteilt sich wie folgt auf die einzelnen Aktivitäten: - Mobiltelefondienst (59,2%); - Festnetztelekommunikation (40,8%): Festnetztelefondienst und Breitband ...

RTA LABORATUVARLARI BIYOLOJIK URUNLER ILAC VE MAKINE SANAYI TICARET 35 Mio $
Logo RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS ist ein in der Türkei ansässiges Unternehmen, das sich mit der Forschung, Entwicklung und Produktion von In-vitro-Diagnostika befasst. Seine diagnostischen Produkte umfassen: Klinische ...

BIOPORTO A/S 92 Mio $
Logo BioPorto A/S

Bioporto A/S ist ein in Dänemark ansässiges Unternehmen, das sich mit der Entwicklung und Vermarktung von in-vitro-diagnostischen (IVD) Assays beschäftigt. Das Portfolio des Unternehmens umfasst fünf Produktkategorien: Der Neutrophile Gelatinase-assoziier ...

QUANTERIX CORPORATION 611 Mio $
Logo Quanterix Corporation

Quanterix Corporation ist ein Unternehmen der Biowissenschaften. Das Unternehmen beschäftigt sich mit der Entwicklung hochempfindlicher digitaler Immunoassay-Plattformen, die die Präzisionsmedizin für die biowissenschaftliche Forschung und Diagnostik förd ...

SOPROCAL, CALERÍAS E INDUSTRIAS S.A. 3 Mio $
Logo Soprocal, Calerías e Industrias S.A.

Soprocal Calerias e Industrias SA ist ein in Chile ansässiges Unternehmen, das sich mit dem Erwerb und der Ausbeutung von Mineralvorkommen sowie der Produktion von Kalziumkarbonat, Branntkalk, Kalkstein, hydraulischem Kalk und anderen damit verbundenen De ...

AROCELL AB 10 Mio $
Logo AroCell AB

AroCell publ AB ist ein in Schweden ansässiges Diagnostikunternehmen, das sich mit der Entwicklung von Markern zur Bestimmung von Zellwachstum (TK 210) und Apoptose beschäftigt. Der wichtigste Produktkandidat des Unternehmens, TK-immuno/hem, ist ein Test ...

CHEILBIO CO., LTD. 41 Mio $
Logo Cheilbio Co., Ltd.

Cheilbio Co., Ltd. ist ein in Korea ansässiges Unternehmen, das in der Herstellung von Tierarzneimitteln tätig ist. Das Angebot des Unternehmens umfasst Antibiotika, antimikrobielle Mittel, Laktobazillen, Enzympräparate, Parasitizide, Antiseptika, organis ...

AMERICAN VIETNAMESE BIOTECH INCORPORATION 19 Mio $
Logo American Vietnamese Biotech Incorporation

American Vietnamese Biotech Incorporation (AmviBiotech) ist ein in Vietnam ansässiges Unternehmen, das in der Pharmaindustrie tätig ist. Das Unternehmen ist in der Herstellung von Medikamenten, Impfstoffen und biologischen Produkten tätig. Außerdem stellt ...

1000MERCIS 62 Mio $
Logo 1000mercis

1000mercis hat sich auf interaktive Werbe- und Marketingdienstleistungen spezialisiert. Der Nettoumsatz verteilt sich wie folgt auf die einzelnen Aktivitäten: - interaktive Marketingdienstleistungen (45,2%): Entwicklung von Marktsegmentstudien und Zufrie ...

SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD. 407 Mio $
Logo Shenzhen Bioeasy Biotechnology Co., Ltd.

Shenzhen Bioeasy Biotechnology Co Ltd ist ein in China ansässiges Unternehmen, das sich hauptsächlich mit der Forschung, der Entwicklung, der Produktion, dem Verkauf und der Bereitstellung von Produkten für Lebensmittelsicherheitstests und damit verbunden ...

SPRING ART HOLDINGS 21 Mio $
Logo Spring Art Holdings

Spring Art Holdings Berhad ist eine in Malaysia ansässige Investment-Holdinggesellschaft. Das Unternehmen ist über seine Tochtergesellschaft Spring Art Industries Sdn. Bhd. hauptsächlich in der Herstellung von einbaufertigen Möbeln tätig, wobei es das Des ...

BIOQUAL, INC. 65 Mio $
Logo Bioqual, Inc.

Bioqual, Inc. erbringt Auftragsforschungsdienstleistungen, die sich auf In-vivo-Modelle menschlicher Krankheiten konzentrieren, darunter COVID-19, das erworbene Immunschwächesyndrom (AIDS), Influenza, Mpox, Infektionen mit dem Respiratory Syncytial Virus ...

APTAMER GROUP PLC 5 Mio $
Logo Aptamer Group plc

Die Aptamer Group plc ist ein in Großbritannien ansässiges Unternehmen, das mit seiner Optimer-Plattform kundenspezifische Affinitätsbinder entwickelt, um neue Ansätze in den Bereichen Therapeutika, Diagnostik und Forschung zu ermöglichen. Die Optimer-Pla ...

BIOVENTIX PLC 286 Mio $
Logo Bioventix PLC

Bioventix plc ist ein in Großbritannien ansässiges Unternehmen, das sich auf die Entwicklung und kommerzielle Bereitstellung von monoklonalen Antikörpern mit hoher Affinität für Anwendungen in der klinischen Diagnostik spezialisiert hat, wie z.B. in autom ...

VIROGATES A/S 7 Mio $
Logo ViroGates A/S

ViroGates A/S ist ein in Dänemark ansässiges Medizintechnikunternehmen. Es entwickelt eine Produktlinie suPARnostic, die die Menge des löslichen Urokinase-Plasminogenaktivator-Rezeptorproteins (suPAR) im menschlichen Blut misst. Der Plasmaspiegel von suPA ...

DIADEXUS, INC. 410 $
Logo Diadexus, Inc.

Diadexus, Inc. ist ein Diagnostikunternehmen. Das Unternehmen befasst sich mit der Entwicklung und Vermarktung von Produkten, die Gesundheitsdienstleistern relevante Informationen für die Behandlung von Patienten im Verlauf von Herzkrankheiten liefern. Zu ...


12Weiter

Insiders

Foto Elisa Patrizi
Elisa Patrizi

Derzeit bekleidet Elisa Patrizi die Position des Head-Operations & Maintenance bei Infrastrutture Wireless Italiane SpA. In der Vergangenheit war Frau Patrizi Manager-Wireless Development bei Telecom Italia SpA. Sie erhielt einen Bachelor-Abschluss von der Universit degli Studi di Roma Tor Vergata.



Foto Francesco Patrizi
Francesco Patrizi

Francesco Patrizi currently works as a Chief Executive Officer & Director at Società Emiliana Trasporti Autofiloviari S.p.A.


Foto Tony Patrizi
Tony Patrizi

Tony Marco Patrizi is the founder of GR Engineering Services Ltd., a company he founded in 2006.
He currently holds the title of Managing Director & Executive Director at the firm.
In addition to his founding position, Mr. Patrizi has also held former positions.
From 2016 to 2018, he served as an Independent Non-Executive Director at Primary Gold Ltd.
He also worked as an Operations Manager at JR Engineering Services Pty Ltd.


Foto Marco Anselmo Patrizi
Marco Anselmo Patrizi

Marco Anselmo Patrizi currently works at Morison KSi Ltd., as Director.






Foto Scott Patrizi
Scott Patrizi

Scott Patrizi is a professional with experience in various non-executive director roles.
He is currently a Non-Executive Director at Forrestania Resources Ltd.
Prior to this, he was the President, Chief Executive Officer & Director at Huntsman Exploration, Inc. from 2021 to 2023.
He also served as a Non-Executive Director at Elixir Energy Ltd.
from 2016 to 2019, and at Rarex Ltd.
from 2016 to 2020.
Additionally, he briefly served as a Non-Executive Director at Caprice Resources Ltd.
in 2021.
Patrizi holds an undergraduate degree from The University of Western Australia Business School.









Foto Elisa
Elisa

Elisa currently works at PT Metro Healthcare Indonesia Tbk, as Manager-Finance & Accounting.



Foto Elisa Massimino
Elisa Massimino

Elisa Massimino is a Trustee at the McCain Institute for International Leadership.
Previously, she served as the President & Chief Executive Officer at Human Rights First.



Foto Elisa Coletti
Elisa Coletti

Elisa Coletti is an economist who currently works at Intesa Sanpaolo.
SpA (Broker) as an Economist Banks.











Foto Elisa Burns
Elisa Burns

Elisa Burns has been a Trustee at Northern Westchester Hospital Association since 2013.


Foto Elisa Newby
Elisa Newby

Dr. Elisa Newby is an Economist at Bank of Finland.
Her current areas of responsibility include preparation of the Bank of Finland’s macroeconomic forecasts and development of forecasting systems and models.
Prior to this she has worked as a lecturer at the University of Cambridge and a researcher at the Centre for Dynamic Macroeconomic Analysis (CDMA) at the University of St Andrews in Scotland.
In 2002–2004, Dr. Newby worked in the Bank of Finland’s Statistics Department, where she was responsible for compiling balance of payments statistics.
In 1999–2002, she served as a derivatives expert on the Helsinki Stock Exchange.
Dr. Newby completed her PhD in Economics at the CDMA in 2007.
Her doctoral dissertation dealt with sustainable monetary policy.
She also has a Master’s degree in Social Sciences from the University of Helsinki.





Foto Elisa Rusu
Elisa Rusu

Elisa Rusu worked at Banca Transilvania SA from 2009 to 2017 as a Manager in the Factoring Department.



Foto Elisa Wilson
Elisa Wilson

Elisa M.
Wilson
is currently serving as an Independent Non-Executive Director at GAMCO Investors, Inc. since 2009.
She is also a Director at GGCP, Inc., Associated Capital Group, Inc., and the American Red Cross of Greater New York.
Additionally, she holds positions as a Director at the Breast Cancer Alliance, Member-BPA Board at Brunswick School, Inc., and Trustee at Boston College.
Ms. Wilson has been the President & Trustee of the Gabelli Foundation, Inc. since 2009.
In terms of education, she has a graduate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from Boston College.



Foto Elisa Perillo
Elisa Perillo

Elisa Perillo worked as a Principal at Umbrella SRL.
She obtained an undergraduate degree from the University of Padua in 2003.


Foto Elisa Brizuela
Elisa Brizuela

Ms. Elisa Brizuela is a Senior Equity Trader at Segall Bryant & Hamill LLC.
Ms. Brizuela is responsible for Segall Bryant & Hamill's Small Cap Equity trading, as well as assisting institutional equity trading.
She has been in the investment industry since 1987.
Prior to joining the firm, she was an international equity trader at Driehaus Capital Management and William Blair Asset Management.







Foto Elisa Dannemiller
Elisa Dannemiller

Ms. Elisa Dannemiller is Chief Medical Officer at Sharklet Technologies, Inc. and a Member at American College of Emergency Physicians.
Ms. Dannemiller was previously employed as a Principal by McKinsey & Co., Inc. She also served on the board at The Denver Business Series.
She received her undergraduate degree from the University of Virginia.










Foto Elisa Nunes
Elisa Nunes

Elisa Nunes has worked as a consultant at Invicta Angels SGPS SA since 2012.



Foto Elisa Pascal
Elisa Pascal

Elisa Pascal has a current job as the Head of Shareholder Relations at Edenred SE.














Foto Elisa Machado
Elisa Machado

Ms. Elisa Machado is a Senior Economist at ARX Investimentos Ltda.
She was previously employed as Economist by Aria Capital, Economic Consultant by Atico Administração de Recursos Ltda., Economist by Icatu Gestão Patrimonial Ltda., Opus Gestão de Recursos Ltda., FUNCEX - Foreign Trade Studies Center Foundation and Bank of America, Consultnat by CBIE – Brazilian Center of Infrastructure, Researcher by IPEA - Institute for Applied Economic Research and Lecturer by PUC-Rio (1996) and Ibmec (2000).
Ms. Machado holds a degree in Economics from Universidade Federal Fluminense and Master's in Economics from Pontifícia Universidade Católica do Rio de Janeiro.


Foto Elisa Waldeck
Elisa Waldeck

Elisa Waldeck is a Member of The Institute of Directors, her current job.
In the past, she worked as a Secretary at Blue Financial Services Ltd.
from 2011 to 2012.












Foto Elisa Rizza Trelewicz
Elisa Rizza Trelewicz

Elisa Rizza Trelewicz is currently working as Vice President & Senior Securities Analyst at Columbus Circle Investors since 2001.
She completed her undergraduate degree from the University of Connecticut in 2000.


Foto Elisa Jagerson
Elisa Jagerson

Elisa Jagerson is a Managing Director at Wildcat where she focuses on investments in Climate Tech SaaS solutions that reduce the effects of climate change.
Her specific areas of interest include AI and Machine Learning (ML) enabled platforms that create disruptive levels of foresight into a future perceived to be unpredictable.
Elisa was most recently CEO of FutureBrand Speck, best known for driving product and service innovation to both market disrupters and industry leaders.
Organizations turned to Elisa and her teams of brand, product, environment and service designers when they needed to accelerate or ‘future proof’ growth.
These products sit today inside our pockets, bodies, hospitals, cars, and data centers, and have generated billions in revenue.
After pioneering ‘experience engineering’, a next generation design thinking methodology credited with infusing reliability into the innovation process, Elisa sold Speck Design to FutureBrand (NYSE: IPG), where she then served on the global leadership team.
Earlier in her career as Founder and CEO of PartsRiver, Elisa pioneered early intelligent data management (IDM) in the transportation industry.
There she acquired $150M in assets from Saqqara and CDC (a Boeing subsidiary), growing PartsRiver into the leading provider of IDM.
Following her success at PartsRiver, Elisa launched and ran Bay Laurel Capital, a micro-cap leveraged buyout firm affiliated with AI LLC.
Elisa began her finance career in global emerging markets, making investments at New York-based private equity firm Zephyr Management and Harare-based ZPF.
Elisa received a BA Cum Laude from Princeton University and an MBA from the Wharton School of Business.



Foto Elisa Dozono
Elisa Dozono

Elisa Dozono currently works as a Director at Oregon Public Broadcasting.



Foto Elisa Weiss
Elisa Weiss

Elisa Weiss currently works as a Director at PearlPoint Cancer Support, Inc.












Keine Ergebnisse zu dieser Suche